Skip to main content
. 2022 Feb 16;2022:6320329. doi: 10.1155/2022/6320329

Table 1.

Comparison of general data between the two groups.

Combined group (n = 25) Control group (n = 17) χ 2/P
Male/female(case) 14/11 10/7 0.325
Age(years) 69.32 ± 5.00 68.71 ± 4.06 0.068
Myeloma types IgG/IgA/light chain (case) 11/8/6 7/5/5 0.765
ISS (International Staging) stage I/stage IIA/stage IIIA/stage IIIB (case) 6/7/8/4 4/5/4/4 0.059